About: A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 03 April 2020

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu n'abril de 2020 (ast) scientific article published on 03 April 2020 (en) наукова стаття, опублікована 3 квітня 2020 (uk)
publication date	wds:Q91553286-3782CB71-8468-48C9-BD76-5E5B5AA0BDF4
publication date	2020-04-03 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q91553286-DD6EF241-61B0-472E-AB79-2B14063216EC
language of work or name	English
rdfs:label	A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV (en)
skos:prefLabel	A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV (en)
name	A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV (en)
author	wds:Q91553286-11C8E2E1-FE19-4FE6-8447-4332F3F63939 wds:Q91553286-23B4A83E-AD21-4B28-AB00-674E3EE1852B wds:Q91553286-429569CF-D461-459D-9886-88958CE895D5 wds:Q91553286-49FED8AB-E99A-4215-80D3-0671943160E3 wds:Q91553286-6D513A46-5503-4B3A-99CB-A743B01D0C31 wds:Q91553286-89534CCC-A57A-4CCA-A597-39702FA504DE wds:Q91553286-9AA89A4C-D438-4A74-A234-330F25A2619F wds:Q91553286-9AC40FD7-E0B6-40BA-8797-95671276ED7F
author	Chris Ka Pun Mok Nicholas C Wu Ian A Wilson Meng Yuan Xueyong Zhu Chang-Chun D Lee Huibin Lv Ray T Y So
title	wds:Q91553286-865DA9DD-8E5F-4617-ACD3-ABD34FC22415
title	A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV (en)
page(s)	wds:Q91553286-FD5ABBAF-877D-4EE8-BD4D-9F8A0EFB2DF8
page(s)	630-633
instance of	wds:Q91553286-0B635B19-E725-46FE-8265-EED50E828A35
instance of	scholarly article
main subject	wds:Q91553286-01E22DFD-F7DC-46E6-ADA3-EB1199A56765 wds:Q91553286-0AF33A15-8243-4906-99C7-2136F5D08BA5
main subject	SARS-CoV-2 COVID-19 mortality
PubMed ID	wds:Q91553286-CEB6A5C3-3A6C-4239-B1FE-D986CECAD207
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32245784
PubMed ID	32245784
published in	wds:Q91553286-227E9E5E-8464-45C8-AAE5-2856AE7130E2
published in	Science
issue	wds:Q91553286-45CA8E2A-5E1C-4E0A-AEC6-2DBB3718A764
volume	wds:Q91553286-B706177E-E5C4-43CB-8053-8B6E7B817BA2
issue	6491
volume	368
DOI	wds:Q91553286-266432F3-3C7C-44B2-8D64-316B84F0B4EE
DOI	http://dx.doi.org/10.1126/SCIENCE.ABB7269
DOI	10.1126/SCIENCE.ABB7269
skos:altLabel	A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV (en)
copyright license	wds:Q91553286-60313356-790f-4be0-9dae-b85f6e424530
copyright status	wds:Q91553286-cf566e0e-3b9e-43cb-b775-412edd63d6f6
copyright license	Creative Commons Attribution 4.0 International
copyright status	copyrighted
Dimensions Publication ID	wds:Q91553286-736A932E-006B-4608-9384-3E953274D7FB
Dimensions Publication ID	1126123270
PMCID	wds:Q91553286-E30CDB4D-E0B9-4DBE-8972-FF5FFFC81A51
PMCID	7164391
COVIDWHO ID	wds:Q91553286-8A58F747-4451-4AA2-8AC7-A3E0F2F8EC05
COVIDWHO ID	covidwho-31567
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91553286
is cites work of	On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2 Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity Human neutralizing antibodies elicited by SARS-CoV-2 infection Convergent antibody responses to SARS-CoV-2 in convalescent individuals Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike Identification of Human Single-Domain Antibodies against SARS-CoV-2 Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2 Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020 Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells Controlling the SARS-CoV-2 spike glycoprotein conformation A thermostable, closed SARS-CoV-2 spike protein trimer Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy Is SARS-CoV-2 Also an Enteric Pathogen with Potential Fecal-Oral Transmission: A COVID-19 Virological and Clinical Review TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals Human leukocyte antigen susceptibility map for SARS-CoV-2 Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19 Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19 A human neutralizing antibody targets the receptor binding site of SARS-CoV-2 Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients Potently neutralizing and protective human antibodies against SARS-CoV-2 Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding Kinetics and isotype assessment of antibodies targeting the spike protein receptor-binding domain of severe acute respiratory syndrome-coronavirus-2 in COVID-19 patients as a function of age, biological sex and disease severity Mechanisms of SARS-CoV-2 entry into cells Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2 The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software